CHEBI:66807 - ochracenomicin A

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name ochracenomicin A
ChEBI ID CHEBI:66807
Definition An angucycline antibiotic that is 3,4,4a,12b-tetrahydrotetraphene-1,7,12(2H)-trione substituted by hydroxy groups at positions 4a, 8 and 12b and a methyl group at position 3. It is isolated from the culture broth of Amycolatopsis sp.MJ950-89F4 and exhibits a broad spectrum of antibacterial potential.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C19H16O6
Net Charge 0
Average Mass 340.32670
Monoisotopic Mass 340.09469
InChI InChI=1S/C19H16O6/c1-9-7-13(21)19(25)15-11(5-6-18(19,24)8-9)16(22)14-10(17(15)23)3-2-4-12(14)20/h2-6,9,20,24-25H,7-8H2,1H3
InChIKey HRKDTQUJICJRIH-UHFFFAOYSA-N
SMILES CC1CC(=O)C2(O)C3=C(C=CC2(O)C1)C(=O)c1c(O)cccc1C3=O
Metabolite of Species Details
Amycolatopsis sp. (NCBI:txid37632) of strain MJ 950-89F4 See: PubMed
Roles Classification
Biological Role(s): antibacterial agent
A substance (or active part thereof) that kills or slows the growth of bacteria.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via angucycline antibiotic )
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
(via angucycline )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing ochracenomicin A (CHEBI:66807) has role antibacterial agent (CHEBI:33282)
ochracenomicin A (CHEBI:66807) is a p-quinones (CHEBI:25830)
ochracenomicin A (CHEBI:66807) is a angucycline antibiotic (CHEBI:70737)
ochracenomicin A (CHEBI:66807) is a phenols (CHEBI:33853)
ochracenomicin A (CHEBI:66807) is a tertiary α-hydroxy ketone (CHEBI:139592)
IUPAC Name
4a,8,12b-trihydroxy-3-methyl-3,4,4a,12b-tetrahydrotetraphene-1,7,12(2H)-trione
Synonym Source
4a,8,12b-trihydroxy-3-methyl-3,4-dihydro-2H-benzo[a]anthracene-1,7,12-trione ChEBI
Citation Waiting for Citations Type Source
7775274 PubMed citation Europe PMC
Last Modified
07 February 2018